London-based trial services co Ergomed has penned a deal with Swedish biotech Asarina Pharma for its Phase IIb trial of sepranolone in patients with…

Cancer-related trials continued to account for the largest number of research studies done by CROs in any region of the world, says a new report.

PPD has expanded its GMP lab operations in Athlone, Ireland, by another 4,300 square feet to conduct analytical testing of biopharmaceuticals and inhalation…

CRO BioPharmaSpec has taken on Dr. Richard Easton as its new technical director of structural analysis and Dr. Mark Millichip, also as technical director, but…

A new contract research org, which has been named Lovelace Biomedical by its parent co, launched this week as it seeks new biotech and pharma partners for…

Premier Research has been given what the company is dubbing a “growth investment” from Metalmark Capital, a New York-based private equity firm--although…

More than 10 years into their drug discovery alliance, Charles River Laboratories and Roche have decided to extend that collaboration for an additional three…

IMARC Research, a CRO based in Strongsville, OH, opens a new office in the Minneapolis area in an effort to gain a bigger share of the medical device market.

Actinium Pharmaceuticals has partnered up with Memphis, TN-based CRO Vector Oncology to help it with a midstage study of its experimental blood cancer med…

R&D